These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29503090)

  • 21. Pharmacological chaperones stabilize retromer to limit APP processing.
    Mecozzi VJ; Berman DE; Simoes S; Vetanovetz C; Awal MR; Patel VM; Schneider RT; Petsko GA; Ringe D; Small SA
    Nat Chem Biol; 2014 Jun; 10(6):443-9. PubMed ID: 24747528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
    Wang H; Liu X; Chen S; Ye K
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders.
    Berman DE; Ringe D; Petsko GA; Small SA
    Neurotherapeutics; 2015 Jan; 12(1):12-8. PubMed ID: 25472693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer's disease iPSC-derived neurons and mice.
    Cusulin C; Wells I; Badillo S; Duran-Pacheco GC; Baumann K; Patsch C
    Mol Cell Neurosci; 2019 Oct; 100():103392. PubMed ID: 31381983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cellular machinery of post-endocytic APP trafficking in Alzheimer's disease: A future target for therapeutic intervention?
    Goldstein LSB; Das U
    Prog Mol Biol Transl Sci; 2021; 177():109-122. PubMed ID: 33453937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease.
    Brownjohn PW; Smith J; Portelius E; Serneels L; Kvartsberg H; De Strooper B; Blennow K; Zetterberg H; Livesey FJ
    Stem Cell Reports; 2017 Apr; 8(4):870-882. PubMed ID: 28285880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced retromer function results in the accumulation of amyloid-beta oligomers.
    Ansell-Schultz A; Reyes JF; Samuelsson M; Hallbeck M
    Mol Cell Neurosci; 2018 Dec; 93():18-26. PubMed ID: 30257187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
    Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
    Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation Signaling in APP Processing in Alzheimer's Disease.
    Zhang T; Chen D; Lee TH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease in a dish: promises and challenges of human stem cell models.
    Young JE; Goldstein LS
    Hum Mol Genet; 2012 Oct; 21(R1):R82-9. PubMed ID: 22865875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human stem cell model of early Alzheimer's disease pathology in Down syndrome.
    Shi Y; Kirwan P; Smith J; MacLean G; Orkin SH; Livesey FJ
    Sci Transl Med; 2012 Mar; 4(124):124ra29. PubMed ID: 22344463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.
    Goetzl EJ; Mustapic M; Kapogiannis D; Eitan E; Lobach IV; Goetzl L; Schwartz JB; Miller BL
    FASEB J; 2016 Nov; 30(11):3853-3859. PubMed ID: 27511944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons.
    van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB
    Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.